Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy
Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960's. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combi...
| Autor principal: | |
|---|---|
| Autores Corporativos: | , |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Lyon, France : Geneva :
International Agency for Research on Cancer ; Distributed by WHO Press
2007.
|
| Colección: | IARC monographs on the evaluation of carcinogenic risks to humans ;
v. 91. |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820317506719 |
| Sumario: | Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960's. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monographs |
|---|---|
| Notas: | At head of title: World Health Organization, International Agency for Research on Cancer. "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005." |
| Descripción Física: | 1 online resource (543 p.) |
| Bibliografía: | Includes bibliographical references and cumulative index. |
| ISBN: | 9781281829610 9786611829612 9789240683211 |
